Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study led by research scientists Andrew Ambrosy, MD, and Alan Go, MD, used artificial intelligence to scan the electronic medical records of patients with a history of heart failure.
Alongside the Great American Smokeout, Kaiser Permanente research supports efforts to promote smoking cessation.
Physician researcher Robert Chang, MD, used a Kaiser Permanente Northern California patient registry to determine a patient's risk of having a large abdominal aortic aneurysm rupture.
Kaiser Permanente study findings highlight the need for patients with primary nephrotic syndrome to be identified as early as possible to prevent complications.
Kaiser Permanente study finds declines in heart attack hospitalizations and emergency care for possible strokes reported during onset of the COVID-19 pandemic not seen in subsequent surges.
Kaiser Permanente study shows computerized interpretation of doctors’ echocardiogram reports can identify patients with aortic stenosis.
COVID-19 patients who are not hospitalized are at low risk of developing blood clots and should not routinely be prescribed blood thinners, a new Kaiser Permanente research letter suggests.
Kaiser Permanente researchers have developed a more precise way to assess a patient's risk of a heart attack, stroke, or other major heart-related problem within the next 60 days.
Kaiser Permanente research shows the need for increased education about the dangers of high blood pressure.
Black patients with heart failure have higher rates of hospitalization for heart failure but lower rates of death than white patients with heart failure, a new Kaiser Permanente study shows.